To determine the genetically causal role of calmodulin in human MASLD, we conducted summary‐data‐based Mendelian randomization (SMR) analysis to assess the causal associations between genetic variants linked to CALM gene expression levels and the risk of MASLD. The gene discussed is CALM2; the disease is metabolic dysfunction-associated steatotic liver disease.